What is a pathology report? How to read yours, section by section

A pathology report is the document a pathologist writes after examining your tissue or sample under a microscope, and it is a single piece of paper that determines your diagnosis and most of what happens next. It usually arrives in pieces over one to two weeks rather than all at once, and in the US it often lands in your patient portal before anyone has called to explain it. This page walks through what each part of the report means and which terms are most commonly misread.

If it appeared on your phone at nine at night and you have been rereading it ever since, that is how a lot of people meet this document.

Who Analyzes Your Results, and Why It Takes Time

A pathologist is a doctor who specializes in diagnosing disease by examining tissue and cells. They rarely meet the patients whose samples they are working on, which is part of why the report reads the way it does. It is written for your oncology team, not for you.

The tissue itself has to be physically processed before anyone can look at it. It is fixed, embedded in wax, sliced extremely thin, mounted on glass slides and stained so that structures become visible. That takes days on its own. Then the pathologist checks the slides and often orders extra stains or molecular tests, which can take a few more days.

This is why the report comes in installments. The initial diagnosis often arrives first. Special stains, hormone receptor(s) and other biomarker results, genomic testing follow separately, sometimes weeks later. Most people have their first results within one to two weeks, though it varies by cancer type and by how complicated the case is.

Two key exceptions exist. A frozen section offers a rapid intraoperative analysis, providing the surgical team with preliminary findings within minutes to guide the extent of resection. While quick, this result is tentative and subject to revision in the final report. Additionally, patients who undergo both a biopsy and a subsequent surgery will receive a distinct report for each procedure.

Understanding Each Section of Your Pathology Report

Reports vary between hospitals, but most contain the same parts in roughly this order.

Clinical information and specimen received

This section notes what tissue was sent, where it came from, how it was labeled, and what background your surgeon shared with the lab. It is always worth double-checking that the listed body site and side (left or right) are accurate.

Gross description

What the tissue looked like to the naked eye before it went under the microscope: size, color, weight, how many pieces. For a needle biopsy this is a few lines. For a mastectomy or a bowel resection it can run to a paragraph of dimensions.

Microscopic description

What was visible under the microscope. This section is the most technical and the least useful to read on your own.

Final diagnosis

The part that matters. Usually a few lines, often with abbreviations, stating what the tissue is.

Synoptic summary

In cancer cases, most accredited labs include a structured checklist based on templates from the College of American Pathologists. It looks like a table of fields and values. It is the most readable part of the report, and it is where the details your oncologist needs are collected in one place.

Comment or note

Where the pathologist explains reasoning, flags uncertainty, or says what further testing is pending. If there is one, read it.

Commonly Misunderstood Terms in Your Report

Grade is not stage

Grade describes how abnormal the cells look under the microscope, usually on a scale of 1 to 3, sometimes written as well, moderately, or poorly differentiated. Stage describes how far the cancer has spread. A grade 3 tumor is not “stage 3.” These two get confused constantly and they mean entirely different things.

In situ is not invasive

In situ means the abnormal cells are still confined to the layer they started in and have not broken through into surrounding tissue. Invasive means they have. This distinction changes treatment substantially.

Margins

When tissue is removed, the surgeon’s cut edges are coated in ink so the pathologist can tell where the specimen ended. A negative or clear margin means no cancer cells were seen at the inked edge. Positive means they were. Close means they were near it, and how near matters differently for different cancers.

Lymph nodes

Usually reported as a fraction, such as 2 of 15, meaning fifteen nodes were examined and two contained cancer.

Lymphovascular invasion

Means cancer cells were seen inside small blood or lymph vessels in the sample. It is one factor among several in assessing risk.

pT, pN, pM

The letter p means the staging is based on what the pathologist found in tissue rather than on imaging. Your final stage combines this with scans and other information.

Finding Answers: What Your Report Reveals and What Comes Next

It describes a sample, not your whole situation

A biopsy report cannot give a stage, because staging depends partly on the size and extent of the tumor, and a biopsy only removes a fragment. If your report has no stage on it, that is expected rather than an omission.

It is not a prognosis

People read grade, node counts and margin status as a score and try to work out their odds. The report does not contain that information. Outcome depends on the full picture, including treatment that has not happened yet, and your oncologist is the person who can put the pieces together.

What Your Margins Really Mean, and Why a Positive Margin Isn’t a Failure

Margins describe the edges of the tissue that was removed. A positive margin typically prompts a discussion about further procedures or supplementary treatment. This represents a standard step in achieving complete removal rather than a surgical error or complication.

Why a “Pending” Status Is Just a Step, Not Bad News

Reports frequently say that further studies are in progress. That means tests are running, not that something alarming has been found.

When Results Aren’t Simple: Navigating Areas of Pathology Uncertainty

The report reads with total confidence, in declarative sentences, with numbers. Most of the time that confidence is warranted. It is still a human interpretation of visual patterns, and interpretations vary.

Studies of second-pathologist review give a consistent picture. Re-reads of outside slides find major discordance leading to a change in management in about 1% of cases. Looking wider than the slides, 88% of patients referred to one academic center from primary care left with a refined or a distinctly different diagnosis than the one they arrived with. Rates are not even across the body: thyroid fine needle aspiration, soft tissue and bone, and neuropathology tend to have higher disagreement rates, while breast and skin tend to be lower.

Several things follow from this.

Many cancer centers re-review outside slides as routine practice before starting treatment. If you are referred, this is likely happening whether or not anyone mentions it. Asking for another pathologist to review the tissue is a normal request and not an accusation about the first pathologist, particularly for rare tumors, unusual histology, or any case where the diagnosis is driving a major surgical decision.

Reports also get amended. An addendum or a revised report usually means new test results arrived, not that a mistake was made.

And some results are genuinely inconclusive. When a pathologist cannot make a diagnosis from what was sampled, the answer is usually a repeat biopsy or further testing rather than speculation.

What Comes Next: Navigating Your Care

Ask for a complete copy of every report, including addenda, and keep them together. You will need them for further opinions, for clinical trial screening, and for any referral.

Four questions that tend to be more useful than trying to decode the document alone:

• In plain words, what is the diagnosis?
• What is still pending, and when will it arrive?
• Is there anything in this report that changes the plan?
• Is my case one where another pathologist’s review would be worth getting?

One practical note. If the report reached your portal before your appointment, it is reasonable to call and ask for a conversation sooner rather than waiting and reading it another thirty times. Most cancer centers have specialist nurses who will talk through a report before you see the consultant, and that is what they are there for.

---

This page explains the structure and vocabulary of pathology reports in general. It cannot interpret yours. Terminology, grading systems and report layouts differ between cancer types and between laboratories, and a term that means one thing in one report may carry different weight in another. Take your report to your own oncology team and ask them to go through it with you.